Last July, the University of California Davis Health System introduced new guidelines governing the relationship between pharmaceutical vendors and the faculty and students engaged in teaching and clinical care there. The policies have been called some of

Photo: Dianna Porter and Ed Coyle of the Alliance for Retired Americans, and Senator Debbie Stabenow (D-MI). On January 24, 2008 PAL held our Annual Dinner in Washington, D.C. Every year, we host this event for the organizations in the PAL Coalition, t

Happy New Year! As we head into 2008 (with one-twelfth of it already done), we here at PAL want to take an opportunity to look back and fondly recall our favority Prescription Access Litigation blog posts of 2007. 2007 was an exciting year for those o

A market research survey of 180,000 docs conducted in the fourth quarter of 2007 found that 19 percent of responding physicians said they refused to see drug reps, no matter what. That sounds like good news, until you get to the part where 73 percent will

Republican primaries in Florida today, so while at least a few talking heads are turned toward the Sunshine State, we figured we’d look that way, too.  In December, we posted on Dr. James Orlowski, singled out for being the only Tampa-area doc to be a reg

...but landed the folks behind "Money Talks: Profits over Patient Safety" on the list of "2008 Notable Video for Adults" by the American Library Association Video Roundtable Committee.    Among the stars of the Kathleen Slattery-Moschkau's documentary on

The director of Prescription Access Litigation (PAL) appears in a documentary called "Money Talks: Profits Before Patient Safety". The film focuses on the questionable marketing tactics of the pharmaceutical industry. A trailer is below: This documenta

A double-issue of the RxP Weekly Reader this week, as PostScript heads down to D.C. for a conference. Happy Reading.   "Not it" say NIH, universities on tracking researcher COI A new report from the Office of the Inspector General of Department of Health

Yesterday two CBS affiliates aired PAL Director Alex Sugerman-Brozan's counter argument to drug industry cronies in a segment about Rx coupons. Watch a clip here! PAL has called on the FDA to ban the use of coupons to promote brand name drugs because we